Flavonoids differentially modulate liver X receptors activity-Structure-function relationship analysis

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Liver X Receptors (LXRs) α (NR1H3) and β (NR1H2) are crucial nuclear receptors regulating cholesterol homeostasis, cell death, and proliferation.
• LXRs are significant therapeutic targets for conditions like dyslipidemia, atherosclerosis, diabetes, and cancer.
• Developing selective LXR ligands is challenging due to isoform specificity requirements.

Purpose of the Study:

• To investigate the potential of selected flavonoids (galangin, quercetin, apigenin, naringenin) to modulate LXR activity.
• To understand the interaction of flavonoids with LXR binding pockets.
• To identify potential selective LXR ligands from natural products.

Main Methods:

• Utilized cell culture experiments with double-hybrid assays to assess LXR modulation.
• Employed in silico molecular docking to predict ligand-binding patterns.
• Screened four specific flavonoids for their effects on LXR activity.

Main Results:

• Demonstrated that specific flavonoids can modulate LXR activity in cell culture.
• Molecular docking provided insights into agonistic and antagonistic binding patterns.
• Identified galangin, quercetin, apigenin, and naringenin as compounds influencing LXR.

Conclusions:

• Flavonoids can modulate Liver X Receptor activity, offering a new avenue for therapeutic development.
• The study enhances understanding of the LXR ligand-binding pocket and flavonoid mechanisms of action.
• Results facilitate the selection and design of more selective LXR ligands for various diseases.